Vericel, formerly Aastrom, in which Dr. Wotton is now a BOD member has its own very successful Patented Bio-reactors, in which its uses the DCM and CLI autologous bone marrow extracted to concentrate stem cells specific to restore healing tissues. While $OCAT is primarily an ESC biotech it also develops ASC therapies. ASC therapies do not require anti-rejection chemicals for those critical tissues related to non-immune privileged body functions such as heart, cartilage, and capillaries.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.